Persistence of Immune Response to an Adjuvanted Varicella‐Zoster Virus Subunit Candidate Vaccine for up to Year 9 in Older Adults

BACKGROUND: In the ZOE-50 and ZOE-70 clinical trials, the candidate herpes-zoster subunit vaccine (HZ/su; 50µg varicella-zoster virus glycoprotein E [gE] and AS01(B) Adjuvant System) demonstrated high efficacy against HZ, with limited waning over 4 years and consistent efficacy across age cohorts. I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Pauksens, Karlis, Volpe, Stephanie, Schwarz, Tino F, Smetana, Jan, Toursarkissian, Nicole, Rombo, Lars, Ravault, Stéphanie, David, Marie-Pierre, Bastidas, Adriana, Oostvogels, Lidia
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631129/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados